NasdaqGS:IDXXMedical Equipment
A Look At IDEXX Laboratories (IDXX) Valuation Following Planned CEO Succession Announcement
IDEXX Laboratories (IDXX) has put a firm CEO succession plan in place, with Michael Erickson set to become President and Chief Executive Officer on May 12, 2026, as Jonathan Mazelsky moves to Executive Chair.
See our latest analysis for IDEXX Laboratories.
The CEO succession news comes after a strong run for long term holders, with the 1 year total shareholder return at 70.57% and the 5 year total shareholder return at 47.25%. The recent 90 day share price return of 11.72% suggests momentum...